Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Widmer

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 1, 2014
Therapeutic drug monitoring in cancer--are we missing a trick?Christophe Bardin, Gareth Veal, Angelo Paci, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2014
Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxicsAngelo Paci, Gareth Veal, Christophe Bardin, et al.
Journal of Mass Spectrometry : JMS|February 21, 2008
Imatinib metabolite profiling in parallel to imatinib quantification in plasma of treated patients using liquid chromatography-mass spectrometryBertrand Rochat, Aurélie Fayet, Nicolas Widmer, et al.
Journal of Hepatology|September 20, 2005
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long termMarkus Neef, Monika Ledermann, Hans Saegesser, et al.
European Journal of Hospital Pharmacy : Science and Practice|February 17, 2026
Business continuity plans for hospital pharmacies: a Delphi consensusFerdinand Le Bloc'h, Laurence Schumacher, Niels Kessler, et al.
Clinical Pharmacokinetics|February 21, 2012
Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levelsVerena Gotta, Nicolas Widmer, Michael Montemurro, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 20, 2018
Comparison against current standards of a DNA aptamer for the label-free quantification of tobramycin in human sera employed for therapeutic drug monitoringEnrico Tenaglia, Anna Ferretti, Laurent A Decosterd, et al.
Therapie|July 12, 2014
[Pharmacokinetic alterations in pregnancy and use of therapeutic drug monitoring]Alice Panchaud, Etienne Weisskopf, Ursula Winterfeld, et al.
Therapeutic Drug Monitoring|September 4, 2019
Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical ReviewEvelina Cardoso, Monia Guidi, Benoît Blanchet, et al.
Revue Medicale Suisse|September 5, 2008
[Principles of therapeutic drug monitoring]Nicolas Widmer, Chantal Csajka, Dominique Werner, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|June 1, 2014
Therapeutic drug monitoring in cancer--are we missing a trick?Christophe Bardin, Gareth Veal, Angelo Paci, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2014
Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxicsAngelo Paci, Gareth Veal, Christophe Bardin, et al.
Journal of Mass Spectrometry : JMS|February 21, 2008
Imatinib metabolite profiling in parallel to imatinib quantification in plasma of treated patients using liquid chromatography-mass spectrometryBertrand Rochat, Aurélie Fayet, Nicolas Widmer, et al.
Journal of Hepatology|September 20, 2005
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long termMarkus Neef, Monika Ledermann, Hans Saegesser, et al.
European Journal of Hospital Pharmacy : Science and Practice|February 17, 2026
Business continuity plans for hospital pharmacies: a Delphi consensusFerdinand Le Bloc'h, Laurence Schumacher, Niels Kessler, et al.
Clinical Pharmacokinetics|February 21, 2012
Therapeutic drug monitoring of imatinib: Bayesian and alternative methods to predict trough levelsVerena Gotta, Nicolas Widmer, Michael Montemurro, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 20, 2018
Comparison against current standards of a DNA aptamer for the label-free quantification of tobramycin in human sera employed for therapeutic drug monitoringEnrico Tenaglia, Anna Ferretti, Laurent A Decosterd, et al.
Therapie|July 12, 2014
[Pharmacokinetic alterations in pregnancy and use of therapeutic drug monitoring]Alice Panchaud, Etienne Weisskopf, Ursula Winterfeld, et al.
Therapeutic Drug Monitoring|September 4, 2019
Therapeutic Drug Monitoring of Targeted Anticancer Protein Kinase Inhibitors in Routine Clinical Use: A Critical ReviewEvelina Cardoso, Monia Guidi, Benoît Blanchet, et al.
Revue Medicale Suisse|September 5, 2008
[Principles of therapeutic drug monitoring]Nicolas Widmer, Chantal Csajka, Dominique Werner, et al.
Pageof 6